Formoterol, a New Long-Acting ß2 Agonist, Inhaled Twice Daily, in Stable Asthmatic Subjects
- 1 April 1992
- Vol. 101 (4) , 1019-1022
- https://doi.org/10.1378/chest.101.4.1019
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Formoterol in the Treatment of Nocturnal AsthmaChest, 1990
- Twelve hours' bronchodilating effect of inhaled formoterol in children with asthma: a double‐blind cross‐over study versus salbutamolClinical and Experimental Allergy, 1990
- Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.Thorax, 1990
- Formoterol, a new long-acting selective β-adrenergic receptor agonist: Double-blind comparison with salbutamol and placebo in children with asthmaJournal of Allergy and Clinical Immunology, 1989
- The use of baselines in clinical trials of bronchodilatorsStatistics in Medicine, 1989
- Formoterol fumarate, a new β2‐adrenoceptor agonistAllergy, 1989
- Formoterol, a new long-acting bronchodilator for inhalationEuropean Respiratory Journal, 1989
- Formoterol and salbutamol metered aerosols: Comparison of a new and an established beta‐2‐agonist for their bronchodilating efficacy in the treatment of childhood bronchial asthmaPediatric Pulmonology, 1989
- Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax, 1988
- Spirometric Studies in Normal Subjects IActa Medica Scandinavica, 1963